Dr. Vyvyane Loh discusses atherosclerotic heart disease, focusing on variability in response to statins, the gap between medical practices and scientific advancements, and the connection between atherosclerosis and autoimmunity. She also explores therapeutic developments targeting inflammation and the significance of glyco-calics in disease development.